Event Overview

Latin America’s rapidly expanding and maturing healthcare markets are undoubtedly a fantastic opportunity for pharmaceutical and medical device companies. The reality, from a market access perspective, is that Latin America is a group of markets with vastly different market access environments. Several markets have well-established HTA and the infrastructure to carry this out; several markets are in the early stages of HTA implementation; several markets continue with International Reference Pricing and the remainder are a mixture of reimbursed and out-of-pocket payment healthcare markets. With a strong and growing private insurer market superimposed on top of all this, the complexity of this region requires a complex solution.

Payers in the region (health plans, sick funds & insurers, payers, health technology assessors, hospital financial management & health department officials) are faced with cost-containment challenges like never before, combined with the consumer expectation for improved healthcare delivery across the region. This is forcing Latin American payers & HTAs to make difficult choices regarding what medical procedures to fund and what expensive medications to reimburse. No longer are “me too” drugs that have achieved regulatory approval simply approved for reimbursement at high prices. Recent advances however, in the sophistication of HTA analysis and modeling, flexible pay for performance models, risk-sharing and value-based pricing schemes, have become increasingly important to mitigate payer risk and allocate financial resources to the areas of pressing need and bring high value, essential medicines and medical devices to the Latin American market.

Pharmaceutical and medical device companies need to use a variety of market access approaches to bring their products to these dynamic markets. A one size- fits-all approach is destined to fail and fit-for-purpose local expertise is essential to deliver the appropriate value message to the appropriate stakeholders in each market. Several markets will require sophisticated value dossiers and thorough levels of economic and clinical outcomes evidence which are at a similar standard as to larger HTAs such as NICE (UK) & HAS (France) which may surprise many pharma and device companies who are naïve to the region.

Speakers List

Payers, HTA Agencies & Policy-Makers

President
Consejo de Salubridad General - Mexican HTA Agency
National Health Council, Ministry of Health, Mexico

Executive Director of Health Technology Assessment and Economic Evaluations
Institute for Clinical Effectiveness and Health Policy (IECS), Argentina
Vice-Chair, INAHTA

Member, The Permanent Advisory Board on Immunization Practices, Ministry of Health, Brazil
Medical Director, Santa Joana Immunization Center, Sao Paulo

Medical Auditor, Head of Oncology Unit
UNIMED, Brazil

 

Legal Advisor
National Resources Fund, Uruguay

President
National Institute of Industrial Property (INPI), Argentina

Industry Experts – Pharmaceuticals

Executive Director, Regional Market Access Latin America | Global Market Access
Merck, USA

Director of Corporate Affairs
Novartis, Brazil

Head of Market Access & Advocacy
Bayer, Brazil

Medical Director
Boehringer Ingelheim, Brazil

(TBC)

Multi-Country Public Affairs Head External Affairs Leader Colombia l Peru
Sanofi, Colombia

Director, Government Policy and Reimbursement
Baxter, Brazil

(TBC)

Value Access & RWE Director Emerging Market West, Global Medical
GSK, Brazil

Industry Experts – MedTech

Director, Market Access, EMEA, Canada & LATAM
Edwards Lifesciences, Switzerland

Market Access & Government Affairs Director
BIOTRONIK, Brazil

Marketing and Market Access Director
LifeMed, Brazil

Health Economics & Market Access Senior Manager
Johnson & Johnson Medical, Brazil

General Director
BioMerieux, Mexico

Senior Manager Public Affairs, LATAM
Edwards Lifesciences, Brazil

Market Access Manager, LATAM
ResMed, Brazil

Latin American Health economics and Market Access Manager
Werfen, Mexico

Experienced Solution Provider

CEO and Founder
ValueConnected

Principal, Lead Latam
CB Partners

Event Structure

Photo Gallery

Event Overview

Latin American Payer & HTA Forum

Day 1 - Session 1 - 2nd June, 2020

Stream Overview

Speakers

President
Consejo de Salubridad General - Mexican HTA Agency
National Health Council, Ministry of Health, Mexico

Executive Director of Health Technology Assessment and Economic Evaluations
Institute for Clinical Effectiveness and Health Policy (IECS), Argentina
Vice-Chair, INAHTA

Member, The Permanent Advisory Board on Immunization Practices, Ministry of Health, Brazil
Medical Director, Santa Joana Immunization Center, Sao Paulo

Medical Auditor, Head of Oncology Unit
UNIMED, Brazil

 

Legal Advisor
National Resources Fund, Uruguay

President
National Institute of Industrial Property (INPI), Argentina

Executive Director, Regional Market Access Latin America | Global Market Access
Merck, USA

Director, Market Access, EMEA, Canada & LATAM
Edwards Lifesciences, Switzerland

CEO and Founder
ValueConnected

Principal, Lead Latam
CB Partners

Pharmaceutical Market Access & RWE in LATAM

Day 2 - Session 2 - 3rd June, 2020

Stream Overview

Speakers

Director of Corporate Affairs
Novartis, Brazil

Head of Market Access & Advocacy
Bayer, Brazil

Medical Director
Boehringer Ingelheim, Brazil

(TBC)

Multi-Country Public Affairs Head External Affairs Leader Colombia l Peru
Sanofi, Colombia

Director, Government Policy and Reimbursement
Baxter, Brazil

MedTech Market Access & Value Demonstration in LATAM

Day 3 - Session 3 - 4th June, 2020

Stream Overview

Speakers

Market Access & Government Affairs Director
BIOTRONIK, Brazil

Marketing and Market Access Director
LifeMed, Brazil

General Director
BioMerieux, Mexico

Senior Manager Public Affairs, LATAM
Edwards Lifesciences, Brazil

Latin American Health economics and Market Access Manager
Werfen, Mexico

  1. Learn how to demonstrate product value to local HTA agencies, regulators and payers.
  2. Hear multiple perspectives from all stakeholders such as the pharmaceutical and medical device industries, academia, HTAs, regulators and payers.
  3. View the potential picture of market growth and market access in Latin America.
  4. Appreciate different market approaches and barriers to market access from the industry perspective.
  5. Understand the market’s affordability and willingness to reimburse innovative, high-cost drugs.
  6. Develop your strategy to become a partner with your customers, not simply a supplier.
  7. Benchmark, network and co-operate with pharma, device & senior-level decision makers in the region.

Pharmaceutical and Medical Device Companies:

Vice-Presidents, Directors, Managers involved in:
Market Access, Pricing & Reimbursement, Health Economics & Outcomes, Government & Stakeholder Relations, Regulatory Affairs, Medical Affairs, Marketing, Therapy Area Heads, Country Managers

Solution providers & consultants:

CEOs, Business Development, Senior Consultants, Regional Heads

Plus:

Independent Academics, Health Economists, Senior Doctors, & Patient Representatives.

Event Partners

This event is accredited for CPD (Continuing Professional Development) status

Media Partners

RECEIVE DISCOUNTED FLIGHTS WHEN YOU REGISTER FOR THIS EVENT WITH

Previous Attendees at Market Access in Latin America - Rio de Janeiro, Brazil, 2018

Company
Job Title
Abbott
Market Access Manager
Abbott
Institutional Business Consultant
Abbott
Marketing Assistant
ABIMED (Brazilian Association of High Technology Industry for Medical Equipment, Products and Supplies)
CEO
Acelity
Market Access Manager
Acelity
Sales Operation Director
Amil (United Healthcare)
Technical Product manager
ANS - National Health Agency
General Manager
ANS - National Health Agency
Director of the health care Provision Directorate
ANVISA
Executive secretary of the Brazilian Drug Market Regulation Chamber (CMED)
Asahi Kasei America
Director
Baxter
Health Economics Senior Manager LATAM
Baxter
Health Economics Manager
Baxter Healthcare
Market Access Manager
BD
Business Head Pharmaceutical System
BMS
Access Associate Director
CBPartners
Senior Vice President
CBPartners
Principal, Lead Latam CoE
CBPartners
Manager, Latam CoE
CSL Behring
Medical Manager
CSL Behring
Market Access Manager
CSL Behring Brazil
President
Drive DeVilbiss Healthcare
VP Sales, Latin America
Drive DeVilbiss Healthcare
Business Agent, Brazil
Edwards Lifescience
Market access Sr Manager for LATAM
Edwards Lifesciences
Director, Market Access, EMEA, Canada & LATAM
GlaxoSmithKline
Regional Real World Evidence and Epidemiology Lead – Latin America
Institute for Clinical Effectiveness and Health Policy (IECS)
Director
Institute of Health Technology Assessment - IETS, Colombia
Former Deputy Director of Health Technology Assessment Institute
Ipsen
Business Support Manager
Ipsen
Key Account Manager
IQVIA
Senior Editor
ISPOR Latin America Consortium
Chair-Elect
Johnson & Johnson Medical
Health Economics & Market Access Senior Manager
MAPE Solutions
Chief Operating Officer
MDM PHARMA BRASIL
Managing Director
Medtronic
Director, Market Access, Government & Public Affairs
Medtronic
Vice President
Mexican Social Security Institute
Director of Innovation and Technological Development
National Resources Fund, Uruguay
Chief Financial Officer
NATS-INC, Ministry of Health, Brazil
Head
Neodent
Director of Quality & Regulatory Affairs
Novartis
Director of Corporate Affairs
Novartis
Pricing & Access Regional Director Latin America & Canada (LACan)
Novartis
Head of Access
Novartis
Access Strategic Manager
Novartis
Region Lead Patient Advocacy, Latin America and Canada
Optum
SVP, Life Sciences
Optum
Commercial Manager
Pharma Star
CEO
Resmed
Market Development Manager Latin America
Roche
HTA & Policy Reimbursement Lead - Latin America
Roche
Commercial Head Latin America
Roche Diagnostics
Medical Access & Value Director
Roche Diagnostics
Market Access Coordinator
Sirtex
VP Global Pricing, Reimbursement & Market Access
Sirtex
EVP Sales and Marketing Americas
Stryker
President Latin America
Takeda
Market Access, Pricing and HEOR Director
Terumo BCT
Sr Manager Market Access
Terumo BCT
Senior Mgr Market Development
Terumo BCT
Medical Science Liaison
Terumo BCT
TS Business Manager
Terumo BCT
Senior Mgr Market Development
UNIMED
Medical Auditor, Head of Oncology Unit
ValueConnected
Managing Director
ValueConnected
Director, Latin America Operations
Vertex
Finance Director Latin America
Vertex
General Manager
Vertex
Patient Advocacy Director
Wellspect Healthcare
Area Sales Manager South America - DEX Markets

Related Videos

Presentation

The economic impact of value on different payment models

Related topics: MedTech, Market Access & HEOR, Latin America
Availability: FREE
  • Overview of main payment mechanisms
  • Basics of hospital financing
  • Activity-based payments: DRG
  • Value-based payments
  • Shift to value: is it happening now?
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Value-Based Reimbursement: including a new procedure in the Brazilian Public Healthcare System (SUS)

Related topics: MedTech, Market Access & HEOR, Latin America
Availability: FREE
  • Quantification of the unmet need for SUS.
  • Development of cost-effectiveness and budget impact analyses.
  • Potential scenarios for SUS with inclusion of technology.
  • Project results and next steps.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

View Agenda or Register